Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV‑1 non-nucleoside reverse transcriptase inhibitors. 2022

Shujing Xu, and Shu Song, and Lin Sun, and Ping Gao, and Shenghua Gao, and Yue Ma, and Dongwei Kang, and Yusen Cheng, and Xujie Zhang, and Srinivasulu Cherukupalli, and Erik De Clercq, and Christophe Pannecouque, and Xinyong Liu, and Peng Zhan
Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, 250012 Jinan, Shandong, PR China.

To explore the chemical space around the entrance channel of the HIV-1 reverse transcriptase (RT) binding pocket, we innovatively designed and synthesized a series of novel indolylarylsulfones (IASs) bearing phenylboronic acid and phenylboronate ester functionalities at the indole-2-carboxamide as new HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) through structure-based drug design. All the newly synthesized compounds exhibited excellent to moderate potency against wild-type (WT) HIV-1 with EC50 values ranging from 6.7 to 42.6 nM. Among all, (3-ethylphenyl)boronic acid substituted indole-2-carboxamide and (4-ethylphenyl) boronate ester substituted indole-2-carboxamide were found to be the most potent inhibitors (EC50 = 8.5 nM, SI = 3310; EC50 = 6.7 nM, SI = 3549, respectively). Notably, (3-ethylphenyl)boronic acid substituted indole-2-carboxamide maintained excellent activities against the single HIV-1 mutants L100I (EC50 = 7.3 nM), K103N (EC50 = 9.2 nM), as well as the double mutant V106A/F227L (EC50 = 21.1 nM). Preliminary SARs and molecular modelling studies are also discussed in detail.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D001897 Boronic Acids Inorganic or organic compounds that contain the basic structure RB(OH)2. Boronic Acid,Acid, Boronic,Acids, Boronic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013450 Sulfones Sulfone
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide

Related Publications

Shujing Xu, and Shu Song, and Lin Sun, and Ping Gao, and Shenghua Gao, and Yue Ma, and Dongwei Kang, and Yusen Cheng, and Xujie Zhang, and Srinivasulu Cherukupalli, and Erik De Clercq, and Christophe Pannecouque, and Xinyong Liu, and Peng Zhan
June 2014, European journal of medicinal chemistry,
Shujing Xu, and Shu Song, and Lin Sun, and Ping Gao, and Shenghua Gao, and Yue Ma, and Dongwei Kang, and Yusen Cheng, and Xujie Zhang, and Srinivasulu Cherukupalli, and Erik De Clercq, and Christophe Pannecouque, and Xinyong Liu, and Peng Zhan
December 2014, Journal of medicinal chemistry,
Shujing Xu, and Shu Song, and Lin Sun, and Ping Gao, and Shenghua Gao, and Yue Ma, and Dongwei Kang, and Yusen Cheng, and Xujie Zhang, and Srinivasulu Cherukupalli, and Erik De Clercq, and Christophe Pannecouque, and Xinyong Liu, and Peng Zhan
March 2011, Journal of medicinal chemistry,
Shujing Xu, and Shu Song, and Lin Sun, and Ping Gao, and Shenghua Gao, and Yue Ma, and Dongwei Kang, and Yusen Cheng, and Xujie Zhang, and Srinivasulu Cherukupalli, and Erik De Clercq, and Christophe Pannecouque, and Xinyong Liu, and Peng Zhan
February 2019, ACS medicinal chemistry letters,
Shujing Xu, and Shu Song, and Lin Sun, and Ping Gao, and Shenghua Gao, and Yue Ma, and Dongwei Kang, and Yusen Cheng, and Xujie Zhang, and Srinivasulu Cherukupalli, and Erik De Clercq, and Christophe Pannecouque, and Xinyong Liu, and Peng Zhan
January 2018, Antiviral chemistry & chemotherapy,
Shujing Xu, and Shu Song, and Lin Sun, and Ping Gao, and Shenghua Gao, and Yue Ma, and Dongwei Kang, and Yusen Cheng, and Xujie Zhang, and Srinivasulu Cherukupalli, and Erik De Clercq, and Christophe Pannecouque, and Xinyong Liu, and Peng Zhan
September 2006, Bioorganic & medicinal chemistry letters,
Shujing Xu, and Shu Song, and Lin Sun, and Ping Gao, and Shenghua Gao, and Yue Ma, and Dongwei Kang, and Yusen Cheng, and Xujie Zhang, and Srinivasulu Cherukupalli, and Erik De Clercq, and Christophe Pannecouque, and Xinyong Liu, and Peng Zhan
December 2012, Journal of medicinal chemistry,
Shujing Xu, and Shu Song, and Lin Sun, and Ping Gao, and Shenghua Gao, and Yue Ma, and Dongwei Kang, and Yusen Cheng, and Xujie Zhang, and Srinivasulu Cherukupalli, and Erik De Clercq, and Christophe Pannecouque, and Xinyong Liu, and Peng Zhan
April 2009, Journal of medicinal chemistry,
Shujing Xu, and Shu Song, and Lin Sun, and Ping Gao, and Shenghua Gao, and Yue Ma, and Dongwei Kang, and Yusen Cheng, and Xujie Zhang, and Srinivasulu Cherukupalli, and Erik De Clercq, and Christophe Pannecouque, and Xinyong Liu, and Peng Zhan
January 2011, Current medicinal chemistry,
Shujing Xu, and Shu Song, and Lin Sun, and Ping Gao, and Shenghua Gao, and Yue Ma, and Dongwei Kang, and Yusen Cheng, and Xujie Zhang, and Srinivasulu Cherukupalli, and Erik De Clercq, and Christophe Pannecouque, and Xinyong Liu, and Peng Zhan
July 2013, ChemMedChem,
Copied contents to your clipboard!